349 related articles for article (PubMed ID: 25234359)
1. Defining a standard set of patient-centered outcomes for men with localized prostate cancer.
Martin NE; Massey L; Stowell C; Bangma C; Briganti A; Bill-Axelson A; Blute M; Catto J; Chen RC; D'Amico AV; Feick G; Fitzpatrick JM; Frank SJ; Froehner M; Frydenberg M; Glaser A; Graefen M; Hamstra D; Kibel A; Mendenhall N; Moretti K; Ramon J; Roos I; Sandler H; Sullivan FJ; Swanson D; Tewari A; Vickers A; Wiegel T; Huland H
Eur Urol; 2015 Mar; 67(3):460-7. PubMed ID: 25234359
[TBL] [Abstract][Full Text] [Related]
2. Re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7.
MacLennan S; Williamson PR; Lam TB
Eur Urol; 2015 Dec; 68(6):e123-4. PubMed ID: 26323947
[No Abstract] [Full Text] [Related]
3. Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach.
Morgans AK; van Bommel AC; Stowell C; Abrahm JL; Basch E; Bekelman JE; Berry DL; Bossi A; Davis ID; de Reijke TM; Denis LJ; Evans SM; Fleshner NE; George DJ; Kiefert J; Lin DW; Matthew AG; McDermott R; Payne H; Roos IA; Schrag D; Steuber T; Tombal B; van Basten JP; van der Hoeven JJ; Penson DF;
Eur Urol; 2015 Nov; 68(5):891-8. PubMed ID: 26129856
[TBL] [Abstract][Full Text] [Related]
4. Reply to Steven MacLennan, Paula R. Williamson, and Thomas B. Lam's Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2015;67:460-7.
Martin NE; Stowell C; Huland H
Eur Urol; 2015 Dec; 68(6):e125-6. PubMed ID: 26320381
[No Abstract] [Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Development of Indicators to Assess Quality of Care for Prostate Cancer.
Nag N; Millar J; Davis ID; Costello S; Duthie JB; Mark S; Delprado W; Smith D; Pryor D; Galvin D; Sullivan F; Murphy ÁC; Roder D; Elsaleh H; Currow D; White C; Skala M; Moretti KL; Walker T; De Ieso P; Brooks A; Heathcote P; Frydenberg M; Thavaseelan J; Evans SM
Eur Urol Focus; 2018 Jan; 4(1):57-63. PubMed ID: 28753751
[TBL] [Abstract][Full Text] [Related]
7. A core outcome set for localised prostate cancer effectiveness trials.
MacLennan S; Williamson PR; Bekema H; Campbell M; Ramsay C; N'Dow J; MacLennan S; Vale L; Dahm P; Mottet N; Lam T;
BJU Int; 2017 Nov; 120(5B):E64-E79. PubMed ID: 28346770
[TBL] [Abstract][Full Text] [Related]
8. Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration.
Rodrigues IA; Sprinkhuizen SM; Barthelmes D; Blumenkranz M; Cheung G; Haller J; Johnston R; Kim R; Klaver C; McKibbin M; Ngah NF; Pershing S; Shankar D; Tamura H; Tufail A; Weng CY; Westborg I; Yelf C; Yoshimura N; Gillies MC
Am J Ophthalmol; 2016 Aug; 168():1-12. PubMed ID: 27131774
[TBL] [Abstract][Full Text] [Related]
9. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review.
Wallis CJD; Glaser A; Hu JC; Huland H; Lawrentschuk N; Moon D; Murphy DG; Nguyen PL; Resnick MJ; Nam RK
Eur Urol; 2018 Jan; 73(1):11-20. PubMed ID: 28610779
[TBL] [Abstract][Full Text] [Related]
10. Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.
Thaker NG; Pugh TJ; Mahmood U; Choi S; Spinks TE; Martin NE; Sio TT; Kudchadker RJ; Kaplan RS; Kuban DA; Swanson DA; Orio PF; Zelefsky MJ; Cox BW; Potters L; Buchholz TA; Feeley TW; Frank SJ
Brachytherapy; 2016; 15(3):274-282. PubMed ID: 26916105
[TBL] [Abstract][Full Text] [Related]
11. Standardization of patient-centered outcomes: less is more.
Ehdaie B; Eastham JA
Eur Urol; 2015 Mar; 67(3):468-9. PubMed ID: 25449205
[No Abstract] [Full Text] [Related]
12. Defining a standard set of patient-centred outcomes for lung cancer.
Mak KS; van Bommel AC; Stowell C; Abrahm JL; Baker M; Baldotto CS; Baldwin DR; Borthwick D; Carbone DP; Chen AB; Fox J; Haswell T; Koczywas M; Kozower BD; Mehran RJ; Schramel FM; Senan S; Stirling RG; van Meerbeeck JP; Wouters MW; Peake MD;
Eur Respir J; 2016 Sep; 48(3):852-60. PubMed ID: 27390281
[TBL] [Abstract][Full Text] [Related]
13. Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force.
Villa S; Kendel F; Venderbos L; Rancati T; Bangma C; Carroll P; Denis L; Klotz L; Korfage IJ; Lane AJ; Magnani T; Mastris K; Rannikko A; Roobol M; Trock B; Van den Bergh R; Van Poppel H; Valdagni R; Bellardita L
Eur Urol; 2017 Feb; 71(2):274-280. PubMed ID: 27720532
[TBL] [Abstract][Full Text] [Related]
14. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
Moris L; Cumberbatch MG; Van den Broeck T; Gandaglia G; Fossati N; Kelly B; Pal R; Briers E; Cornford P; De Santis M; Fanti S; Gillessen S; Grummet JP; Henry AM; Lam TBL; Lardas M; Liew M; Mason MD; Omar MI; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; van Der Kwast TH; van Der Poel HG; Willemse PM; Yuan CY; Konety B; Dorff T; Jain S; Mottet N; Wiegel T
Eur Urol; 2020 May; 77(5):614-627. PubMed ID: 32146018
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.
Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
Eur Urol; 2016 May; 69(5):844-51. PubMed ID: 26525837
[TBL] [Abstract][Full Text] [Related]
16. Choosing Wisely Canada cancer list: ten low-value or harmful practices that should be avoided in cancer care.
Mitera G; Earle C; Latosinsky S; Booth C; Bezjak A; Desbiens C; Delouya G; Laing K; Camuso N; Porter G
J Oncol Pract; 2015 May; 11(3):e296-303. PubMed ID: 25980018
[TBL] [Abstract][Full Text] [Related]
17. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
[TBL] [Abstract][Full Text] [Related]
18. Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study.
Alemozaffar M; Sanda M; Yecies D; Mucci LA; Stampfer MJ; Kenfield SA
Eur Urol; 2015 Mar; 67(3):432-8. PubMed ID: 24582327
[TBL] [Abstract][Full Text] [Related]
19. Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.
Laviana AA; Zhao Z; Huang LC; Koyama T; Conwill R; Hoffman K; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
Eur Urol; 2020 Aug; 78(2):248-255. PubMed ID: 32098731
[TBL] [Abstract][Full Text] [Related]
20. Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy.
Wagner AA; Cheng PJ; Carneiro A; Dovirak O; Khosla A; Taylor KN; Crociani CM; McAnally KC; Percy A; Dewey LE; Sanda MG; Chang P
J Urol; 2017 Jan; 197(1):109-114. PubMed ID: 27475967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
